electroCore (ECOR) announced that Elena Bonfiglioli has been appointed to electroCore’s Board of Directors, effective September 2, 2025. Ms. Bonfiglioli’s appointment follows the retirement from the Board of Peter Cuneo. She currently serves as Microsoft’s (MSFT) Global Business Leader for Healthcare, Pharma Life Sciences, and the International clinical applications’ solutions, responsible for go-to-market, commercial, and partnerships, enabling artificial intelligence transformation initiatives in health providers, payors and Life Sciences’ organizations globally.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ECOR:
- electroCore appoints Benning as SVP of Truvaga
- ElectroCore’s Earnings Call: Record Revenue Amid Challenges
- ElectroCore’s Promising Growth and Strategic Initiatives Justify Buy Rating with $25 Price Target
- Electrocore Reports Strong Revenue Growth in Q2 2025
- electroCore appoints James Theofilos to board of directors